The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
about
Telbivudine for chronic hepatitis BMutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.Regio- and enantioselective N-allylations of imidazole, benzimidazole, and purine heterocycles catalyzed by single-component metallacyclic iridium complexes.Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.
P2860
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@en
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@nl
type
label
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@en
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@nl
prefLabel
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@en
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@nl
P2860
P356
P1476
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.
@en
P2093
Hans Ludger Tillmann
P2860
P304
P356
10.2147/TCRM.S1965
P577
2008-08-01T00:00:00Z